Thomson Reuters Launches Asthma Disease Partnership Program – PR Newswire (press release)

Thomson Reuters Launches Asthma Disease Partnership Program
PR Newswire (press release)
PHILADELPHIA, Feb. 26, 2013 /PRNewswire/ — The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced the launch of MetaMinerâ„¢ Asthma,

and more »

View full post on asthma – Google News

Attacking Asthma: Program to keep kids out of hospital saves tax dollars, but … – San Jose Mercury News

Attacking Asthma: Program to keep kids out of hospital saves tax dollars, but
San Jose Mercury News
Like every other young patient treated on the Breathmobile, an asthma clinic on wheels, Tyree, 13, receives respiratory exams, medication, equipment and periodic checkups that help control his asthma, all for free. His experience illustrates that

View full post on asthma – Google News

Attacking Asthma: Program to keep kids out of hospital saves tax dollars, but … – Inside Bay Area

Attacking Asthma: Program to keep kids out of hospital saves tax dollars, but
Inside Bay Area
Like every other young patient treated on the Breathmobile, an asthma clinic on wheels, Tyree, 13, receives respiratory exams, medication, equipment and periodic checkups that help control his asthma, all for free. His experience illustrates that

and more »

View full post on asthma – Google News

Attacking Asthma: Program to keep kids out of hospital saves tax dollars, but … – Contra Costa Times

Attacking Asthma: Program to keep kids out of hospital saves tax dollars, but
Contra Costa Times
Like every other young patient treated on the Breathmobile, an asthma clinic on wheels, Tyree, 13, receives respiratory exams, medication, equipment and periodic checkups that help control his asthma, all for free. His experience illustrates that

and more »

View full post on asthma – Google News

GlaxoSmithKline initiates Phase III refractory asthma program – Equities.com

GlaxoSmithKline initiates Phase III refractory asthma program
Equities.com
The Phase III program includes two key studies: MEA115588: A 32-week multicenter, randomized, double-blind, double-dummy, placebo-controlled study in patients with severe uncontrolled refractory asthma. The primary endpoint of the study is to evaluate
Glaxo Starting Late-Stage Study of Asthma DrugPharmaceutical Processing
GlaxoSmithKline starts final-stage tests on severe asthma drugFox News
GSK takes severe asthma antibody into phase IIIPMLiVE
Zenopa –Fox Business –WHTC
all 25 news articles »

View full post on asthma – Google News